Ossicodone E Naloxone (Naloxone, Oxycodone)

Oxycodone, the active ingredient in Ossicodone E Naloxone, is an opioid analgesic presented as a combination tablet for oral use. It treats moderate to severe pain in adult patients when opioid therapy is needed. Naloxone, the second active ingredient, is an opioid antagonist included to reduce misuse potential. GNH USA supplies Ossicodone E Naloxone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Ossicodone E Naloxone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ossicodone E Naloxone is used primarily for pain management within the opioid pathway.

- Moderate to severe acute pain: Provides rapid analgesia while limiting opioid‑related adverse effects. - Chronic cancer‑related pain: Maintains long‑term pain control in oncology patients. - Post‑operative pain: Facilitates recovery by managing surgical pain after major procedures.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea and vomiting: Frequent gastrointestinal upset. - Constipation: Reduced bowel motility common with opioid use. - Dizziness or light‑headed dizziness: May occur during dose titration. - Sedation: Feelings of drowsiness or reduced alertness. - Dry mouth: Reduced salivation. - Pruritus: Itching, often mild.

Serious or Rare Side Effects: - Respiratory depression: Marked reduction in breathing rate. - Severe hypotension: Sudden drop in blood pressure. - Seizure: Uncommon but reported. - Allergic reactions: Rash, hives, or anaphylaxis. - Opioid withdrawal symptoms: May appear if naloxone becomes active. - Hepatotoxic t  t          t  t  t t t t t t t t t t

When ​          ...  ...  ... … 

-     ...  ...